Cardinal Health has announced to sell its Pharmaceutical Technologies and Services (PTS) unit to the Blackstone Group for approximately $3.3 billion. As a part of the deal, Blackstone would take over the PTS businesses of Cardinal that develop and manufacture package medication and other pharma products. Cardinal, the leading provider of the products and services supporting the health care industry, unleashed its plans to divest the segment to utilise its resources. The money generated from the proceeding would then be utilised to repurchase the shares of Cardinal Health.
For Complete IIPM Article, Click on IIPM Article
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2007
An IIPM and Malaya Chaudhuri – Arindam Chaudhuri Initiative
No comments:
Post a Comment